Is UFP Technologies (UFPT) Undervalued After Argus Lifted Its Price Target?

Argus raised its price target for UFP Technologies (UFPT) to $334, citing strong recent performance and growth prospects. The stock has gained 34.60% year-to-date and 54.03% over one year. Analysts estimate a fair value of $355, but the stock trades at a P/E of 32.2x, higher than its industry average. The company's expansion and medical sector focus drive optimism, though risks include customer concentration and integration challenges.

Original reporting
Published Oct 5, 2026, 2:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 5:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$UFPT
Bullish
medium confidence
Mentioned
$UFPT
Relevance
6/10
AlphAI data visualization · based on simplywall.st
Decision brief

The 30-second read

$UFPTBullishMed
01

Why it matters

Analyst target upgrades can prompt short‑term buying, but fundamentals and customer concentration remain key risks.

02

Market read

Analyst price target increase provides a modest trading catalyst for UFPT.

03

What to watch

Potential integration risk from recent acquisitions and concentration risk.

Relevance 6/10Novelty 6/10Timing: today

Background

The article reviews UFP Technologies' recent performance and Argus' new price objective.

Company-level read

Ticker impact

$UFPTBullishMedium confidence
Context

Argus raised its price target for UFP Technologies to $334, indicating a fresh analyst upgrade.

Expected impact

likely upward pressure as investors reassess valuation

Evidence & confidence

Analyst target lifts often trigger buying interest, especially after a strong price run.

Market effects

May lift sentiment for other medical packaging peers.

Limited to U.S. small‑cap biotech/medical device space.

Low

Counterpoint

Target raise could be premature if reliance on few large customers persists.

Key entities

  • UFP Technologies

    Medical packaging specialist (ticker UFPT).

  • Argus

    Research firm that raised the price target.

Related articles

$UFPTMed

UFP Technologies (UFPT) Shares Just Moved, So What Is Driving Attention Now?

UFP Technologies (UFPT) reported Q3 sales of $172.43M and net income of $20.62M, up from the previous year. Shares rose 17.66% to $329.82 on the news, extending a 15.32% 7-day return. Analysts see a fair value of $355, citing growth in medical device components and packaging. However, UFPT trades at 33.4x earnings, higher than the industry average of 23.9x, raising valuation concerns.

$UFPTMed

UFP Technologies (UFPT) Q3 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q3 2026 sales up 11.6%, with organic growth at 11.1%. Gross margin improved to 29.4% from 27.7% last year. Adjusted EPS was $2.88, up significantly. The company is investing in growth, including acquisitions like CI Medical, and expanding credit facilities. AJR operations are behind schedule but expected to improve in 2027. Management remains optimistic about long-term growth and shareholder value.

$UFPTHighAI 8/10

UFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026

UFP Technologies (UFPT) reported Q3 2026 revenue of $172.4M, up 11.6% YoY and 3.2% above estimates. Adjusted EPS of $2.88 beat estimates by 7.3%. Operating margin held steady at 16%. The company cited operational improvements and growth in new programs. Analysts expect 5.6% revenue growth over the next 12 months.

$UFPTHigh

UFP Technologies Announces Strong Q3 Results

UFP TECHNOLOGIES INC (UFPT) filed an SEC Form 8-K — Results of Operations and Financial Condition. UFP Technologies Announces Strong Q3 Results Newburyport, Mass., November 3, 2026. UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly